1. 1843PMolecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial. (23rd October 2018) Authors: Vuagnat, P; Baldini, C; Verlingue, L; Martin Romano, P; Varga, A; Hollebecque, A; Postel-Vinay, S; Gazzah, A; Bahleda, R; Marabelle, A; Ribrag, V; Champiat, S; Michot, J-M; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 296PApplicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs). (23rd October 2018) Authors: Vozy, A; Simonaggio, A; Auclin, E; Mezquita, L; Baldini, C; Martin-Romano, P; Pistilli, B; Gazzah, A; Bahleda, R; Ribrag, V; Postel-Vinay, S; Champiat, S; Soria, J-C; André, F; Massard, C; Besse, B; Delaloge, S; Varga, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial. (4th October 2019) Authors: Moro-Sibilot, D; Cozic, N; Pérol, M; Mazières, J; Otto, J; Souquet, P J; Bahleda, R; Wislez, M; Zalcman, G; Guibert, S D; Barlési, F; Mennecier, B; Monnet, I; Sabatier, R; Bota, S; Dubos, C; Verriele, V; Haddad, V; Ferretti, G; Cortot, A Journal: Annals of oncology Issue: Volume 30:Number 12(2019) Page Start: 1985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. (22nd May 2019) Authors: Henon, C; Blay, J -Y; Massard, C; Mir, O; Bahleda, R; Dumont, S; Postel-Vinay, S; Adam, J; Soria, J -C; Le Cesne, A Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O-001Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors. (20th June 2018) Authors: Meric-Bernstam, F; Arkenau, H; Tran, B; Bahleda, R; Kelley, R; Hierro, C; Ahn, D; Zhu, A; Javle, M; Winkler, R; He, H; Huang, J; Goyal, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O-001Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors. (20th June 2018) Authors: Meric-Bernstam, F; Arkenau, H; Tran, B; Bahleda, R; Kelley, R; Hierro, C; Ahn, D; Zhu, A; Javle, M; Winkler, R; He, H; Huang, J; Goyal, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OS4.3 Feasibility and benefit of Molecular Profiling to Guide Enrollment of Patients with Recurrent Gliomas in Early Phase Trials. (6th September 2019) Authors: Baldini, C; Younan, N; Castanon Alvarez, E; Bahleda, R; Hollebecque, A; Dhermain, F; Ammari, S; Alentorn, A; Dumont, S; Frenel, J; Di Stefano, A; Bielle, F; Hoang-Xuan, K; Delattre, J; Soria, J; Sanson, M; Idbaih, A; Massard, C; Touat, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial. (13th September 2018) Authors: Colevas, A D; Bahleda, R; Braiteh, F; Balmanoukian, A; Brana, I; Chau, N G; Sarkar, I; Molinero, L; Grossman, W; Kabbinavar, F; Fassò, M; O'Hear, C; Powderly, J Journal: Annals of oncology Issue: Volume 29:Number 11(2018) Page Start: 2247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗